Sign Up to like & get
recommendations!
1
Published in 2017 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-017-1137-7
Abstract: Poly (ADP-ribose) polymerase (PARP) inhibitors have attracted much attention as one of the major molecular-targeted therapeutics for inhibiting DNA damage response. The PARP inhibitor, olaparib, has been clinically applied for treating certain recurrent ovarian cancer…
read more here.
Keywords:
targeting dna;
cancer clinical;
advances targeting;
ovarian cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "RSC Advances"
DOI: 10.1039/c9ra06908a
Abstract: Gene targeting involves integration of foreign DNA into the fungal genome by several strategies including Agrobacterium tumefaciens-mediated transformation (ATMT).
read more here.
Keywords:
genes involved;
involved synthesis;
expression genes;
advances targeting ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Pharmaceutical Development and Technology"
DOI: 10.1080/10837450.2021.1948568
Abstract: Abstract Malaria, as one of the most common human infectious diseases, remains the greatest global health concern, since approximately 3.5 billion people around the world, especially those in subtropical areas, are at the risk of…
read more here.
Keywords:
drug;
advances targeting;
recent advances;
targeting malaria ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2152325
Abstract: ABSTRACT Introduction Endometriosis is an estrogen-dependent disease on the background of progesterone resistance. Increased estrogen production, low estrogen metabolization, and altered estrogen receptors (ERs) expression contribute to the hyperestrogenic milieu within endometriotic lesions. Since estrogens…
read more here.
Keywords:
estrogen;
disease;
synthesis receptors;
advances targeting ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Cell and Developmental Biology"
DOI: 10.3389/fcell.2022.942500
Abstract: Kinases still remain the most favorable members of the druggable genome, and there are an increasing number of kinase inhibitors approved by the FDA to treat a variety of cancers. Here, we summarize recent developments…
read more here.
Keywords:
kinases pseudokinases;
advances targeting;
biology;
recent advances ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22042201
Abstract: Infection by oncogenic human papillomavirus (HPV) is the primary cause of cervical cancer and other anogenital cancers. The majority of cervical cancer cases occur in low- and middle- income countries (LMIC). Concurrent infection with Human…
read more here.
Keywords:
infection potential;
infection;
cervical cancer;
advances targeting ... See more keywords